Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers

Summary

The primary objective is to evaluate the clinical benefit of CureXcell® as adjunct to Standard of Care in the treatment of Chronic Venous Leg Ulcers. CureXcell® is a cell based therapy, containing activated homologous white blood cells prepared from donated healthy whole blood. A total of 252 patients will be randomized to receive either CureXcell® or Placebo.

Timeline

Start

2014-05

Primary completion

2016-05

Completion

2016-06

Drugs

Indications